MolecuLight
Cross-source consensus on MolecuLight from 1 sources and 5 claims.
1 sources · 5 claims
Uses
How it works
Benefits
Evidence quality
Highlighted claims
- MolecuLight identified additional fluorescent areas after standard radical debridement in all ten cases. — Can a fluorescent imaging device (MolecuLight) function as an adjunct to surgical debridement during revision knee arthroplasty for periprosthetic infection in a tertiary centre: a feasibility study
- The study did not establish that fluorescence-guided debridement improves clinical outcomes or infection control. — Can a fluorescent imaging device (MolecuLight) function as an adjunct to surgical debridement during revision knee arthroplasty for periprosthetic infection in a tertiary centre: a feasibility study
- MolecuLight was assessed as an adjunct after standard radical debridement during revision knee arthroplasty for chronic periprosthetic joint infection. — Can a fluorescent imaging device (MolecuLight) function as an adjunct to surgical debridement during revision knee arthroplasty for periprosthetic infection in a tertiary centre: a feasibility study
- MolecuLight detects endogenous fluorescence from common wound bacteria without requiring contrast agents or topical tracers. — Can a fluorescent imaging device (MolecuLight) function as an adjunct to surgical debridement during revision knee arthroplasty for periprosthetic infection in a tertiary centre: a feasibility study
- The study supports the feasibility of using MolecuLight intraoperatively because it identified fluorescent areas in every patient and yielded microbiological confirmation in most cases. — Can a fluorescent imaging device (MolecuLight) function as an adjunct to surgical debridement during revision knee arthroplasty for periprosthetic infection in a tertiary centre: a feasibility study